Several pathways related to innate immune response were shown to be activated in the progression of CKD, such as the NF-κB system, the Toll-like receptor (TLRs 1–9) signaling pathway, the NOD2 receptor and the NLRP3 inflammasome11, 12, 16–26. Here, NFKB1 is linked to chronic kidney disease.